IB

Iqra Basharat Qurashi

Active Director Director DIN 11499076
DIN 11499076 First appointment Jan 2026 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jan 2026
Shareholding value β€’β€’β€’β€’ Premium profile

About Iqra Basharat Qurashi

Data last updated:

Iqra Basharat Qurashi is a Director at La3eb Pharmaceuticals Private Limited (since 2026). The company operates in Pharma.

DIN 11499076
Primary Designation Director
Industry Pharma
First Appointment 21 Jan 2026

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director21 Jan 20262026Active

Board colleagues of Iqra Basharat Qurashi

NameDINCompanyDesignation
Shanoo Ashraf11499077La3eb Pharmaceuticals Private LimitedDirector

Directorship timeline

Open interactive timeline →
La3eb Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Iqra Basharat Qurashi

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Iqra Basharat Qurashi

Iqra Basharat Qurashi currently holds 1 directorship: La3eb Pharmaceuticals Private Limited (Director, since 21 Jan 2026).

Iqra Basharat Qurashi was first appointed on 21 Jan 2026 as Director at La3eb Pharmaceuticals Private Limited.

The current boards of Iqra Basharat Qurashi's companies include Shanoo Ashraf (La3eb Pharmaceuticals Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available